English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduRemission Medical announced a partnership with Sentara Health to increase access to Rheumatology care for adult patients.
Tag: Rheumatic Disease
Press Registration Now Open for ACR Convergence 2022
The American College of Rheumatology (ACR) is providing complimentary registration to journalists wishing to write about studies presented at ACR Convergence 2022, the ACR’s annual meeting taking place Nov. 10 – 14.
Pathway uncovered for greatest lupus genetic risk factor, study shows
Researchers at Michigan Medicine have uncovered the enigmatic mechanism that genetically predisposes people to the worst effects of the most typical form of lupus, a study suggests. Researchers say the findings could potentially facilitate the discovery of safe, simple and effective treatments.
ACR Statement on Access to Reproductive Healthcare
The American College of Rheumatology (ACR) is deeply concerned about the U.S. Supreme
Court’s Dobbs v. Jackson ruling because it negatively impacts the practice of rheumatology.
Disease control, safe medications critical to pregnancies for women with rheumatic disease
Pregnant women with active rheumatic disease carry a higher risk of adverse outcomes than the general population including hypertension, preeclampsia, higher cesarean section rate, small for gestational aged infants, preterm delivery, and fetal loss. To decrease the risk of these complications, rheumatic disease should be under control before conception with medications that are safe to use during pregnancy.
Study Observes Worse COVID-19 Vaccine Response in Patients Taking Glucocorticoids or B-Cell Therapies
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive therapy appear to have an impaired immunity response to SARS-CoV-2, the coronavirus that causes COVID-19, vaccines. Patients currently on glucocorticoids or B-cell depleting therapy appear to have an even more severely impeded vaccine response.
Study Finds Treat-to-Target ULT Strategy Manages Gout Effectively and Safely with No Cardiovascular Toxicity
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that allopurinol and febuxostat may effectively lower urate levels when used in a treat-to-target approach. Importantly, both urate-lowering therapies were very effective with 90% of patients reaching target urate levels. Additionally, both appeared safe, with no evidence of increased cardiovascular toxicity.
Infection Rates in Psoriatic Arthritis Patients on Biologics Have Decreased, According to National Data
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows significant decreases in infections among people with psoriatic arthritis over the years 2012-2017.
Study Finds Systemic Autoimmune Disease Patients Fare Well After Transplants, Making Surgery a Viable Treatment Option for End-Stage Lung Disease
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with systemic autoimmune diseases do as well after lung or heart-lung transplants as those without any systemic causes of end-stage lung disease.
Patients with rare scleroderma have deadlier organ damage, despite getting standard treatment
Patients with a rare form of scleroderma that causes more skin thickening have a greater chance of dying from related heart, lung and kidney problems, a new study found. This occurs despite the patient population taking drugs used to treat most people with scleroderma. Researchers say it is an opportunity for more targeted drug development.
Town Hall on Effectiveness of COVID-19 Vaccination in Immunosuppressed Patients Hosted by the American College of Rheumatology
How effective COVID-19 vaccines’ have been in immunosuppressed and rheumatic disease patients remains an incompletely answered question. The American College of Rheumatology (ACR) has organized an expert panel to share what we are learning from real-world data and answer questions.
ACR COVID-19 Vaccine Guidance Recommends Vaccination, Addresses Immunosuppressant Drugs & Patient Concerns
The American College of Rheumatology (ACR) has released its COVID-19 Vaccine Clinical Guidance Summary that provides an official recommendation to vaccinate rheumatology patients with musculoskeletal, inflammatory and autoimmune diseases. Important considerations and caveats on how to approach vaccination are included for patients with high disease activity and/or those taking immunosuppressant treatments.
Protein Linked to Progressive Lung Scarring in Scleroderma Patients
Osteopontin is discovered as the culprit behind these patients’ main cause of death. However, a repurposed immunosuppressive drug may combat the pro-inflammatory protein.
COVID-19 Infection Rates Low in People with Rheumatic Diseases, Most Report Mild Illness
A new study shows that the COVID-19 infection incidence has been low in people with rheumatic diseases, and most of those infected experience a mild course of illness. Additionally, fatalities have been low among rheumatic disease patients infected with COVID-19. Details of this research was presented at ACR Convergence, the American College of Rheumatology’s annual meeting.
Minority Patients with Rheumatic Diseases Have Worse COVID-19 Outcomes, More Likely to Be Hospitalized
New research at ACR Convergence, the American College of Rheumatology’s annual meeting, reveals that people of color with rheumatic disease have worse health outcomes from COVID-19 infection, are more likely to be hospitalized to treat their coronavirus infection, and are more likely to require invasive ventilator treatment.
ACR Responds to CY2021 Medicare Physician Fee Schedule
In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) applauded the agency for continuing to recognize the value of rheumatology, by affirming changes to E/M reimbursement to better reflect the work and expertise needed to treat complex patient populations.
American College of Rheumatology Secures $7M Grant to Address Gaps in Lupus Care and Treatment
The American College of Rheumatology (ACR) was recently awarded a $7M grant to reduce inequities in symptom recognition, care and disease management of systemic lupus erythematosus (lupus). The grant, which will be led by the ACR’s Collaborative Initiatives (COIN) department, begins on Sept. 30.
Rheumatology Leaders and Patient Advocates Urge Congress to Address Care Challenges Exacerbated by COVID-19 During Advocates for Arthritis
The American College of Rheumatology (ACR) will hold its first virtual Advocates for Arthritis event on Tuesday, Sept. 15, where more than 120 rheumatologists, rheumatology health professionals, and patient advocates will meet with lawmakers via video to discuss the healthcare challenges they are facing in the midst of COVID-19.
“My Disease May Be Invisible, But I’m Not”: Patients Tell Their Stories During Rheumatic Disease Awareness Month
The American College of Rheumatology (ACR) and Simple Tasks™ will recognize the fifth annual Rheumatic Disease Awareness Month (RDAM) this September with an awareness campaign that focuses on amplifying patient voices and experiences.
Press Registration Opens for ACR Convergence 2020
The American College of Rheumatology (ACR) and the Association for Rheumatology Professionals (ARP) welcomes members of the press to write about research presented at ACR Convergence 2020, the ACR’s annual meeting
American College of Rheumatology’s Annual Meeting Pivots to All-Virtual Format
In keeping with global efforts to stem the spread of SARS-CoV-2 (COVID-19), the American College of Rheumatology (ACR) will take its annual, face-to-face meeting virtual. ACR Convergence will take place online Nov. 5 – 9.
During Virtual Hill Visits, Rheumatology Leaders Urge Lawmakers to Provide Targeted COVID-19 Relief for Healthcare Practices
In virtual meetings with lawmakers and on Twitter tomorrow, physician and health professional leaders from the American College of Rheumatology are sounding the alarm about the economic impact of COVID-19 on rheumatology practices and the urgent need for targeted relief to help specialty practices remain solvent and continue to serve patients.
ACR Releases First Guideline to Address Reproductive Health for Patients with Rheumatic Diseases
This is the first, evidence-based guideline related to the management of reproductive health issues for all patients with rheumatic diseases. With 131 recommendations, the guideline offers general precepts that provide a foundation for its recommendations and good practice statements.
Complimentary Press Registration Available for ACR’s 2020 State of the Art Clinical Symposium
The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented at the State-of-the-Art Clinical Symposium (SOTA) in New Orleans on March 27-29.
ACR and EULAR Release New Classification Criteria for IgG4-Related Disease
The American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) released the 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease. It is the first criteria developed specifically for this recently recognized disease.
HSS Experts Share Best Practices for Developing and Implementing Effective Educational Programs for Diverse Patients with Rheumatic Conditions
At the 2019 American College of Rheumatology/Association of Rheumatology Professionals annual meeting in Atlanta, experts from the HSS Education Institute at Hospital for Special Surgery (HSS) presented their method for developing and implementing effective educational programs for diverse patients with rheumatic conditions.